AbbVie | ABBV - Trade Creditors


AbbVie reported $3.59B in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Abbott USD 4.68B 439M Mar/2026
ALKERMES USD 142.86M 40.5M Jun/2026
Amgen USD 2.86B 16.65B Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Coherus Biosciences USD 13.17M 1.69M Jun/2026
Eisai JPY 87.53B 11.64B Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
J&J USD 9.22B 1.24B Jun/2026
Medtronic USD 2.57B 12M Dec/2025
Merck USD 3.86B 541M Mar/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Novartis USD 4.26B 64M Jun/2026
Pacira USD 17.51M 3.5M Jun/2026
Perrigo USD 400.4M 34.4M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sanofi EUR 23.6B 888M Jun/2026
UCB EUR 4.04B 755M Dec/2025
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
United Therapeutics USD 498.3M 491.2M Mar/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026
Zoetis USD 507M 20M Mar/2026